Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Gibbons · SciRah

Researcher profile · Semantic Scholar

D. Gibbons

Share profile

D. Gibbons — researcher profile on SciRah

h-index: 71
Works: 386
Citations: 16K

Most-cited papers

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
T. Cascone, C. Leung, A. Weissferdt, A. Pataer +53 more
2023Nature Medicine207 citations Open access
Semantic Scholar
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Arvind Ravi, M. Hellmann, Monica B. Arniella, Mark Holton +38 more
2023Nature Genetics171 citations Open access
Semantic Scholar
Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
M. Negrao, H. Araújo, G. Lamberti, Alissa J Cooper +62 more
2023Cancer Discovery136 citations Open access
Semantic Scholar
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T. Kim, Yan-Shuo Chu, Mercy Misoi, M. Suarez-Almazor +34 more
2022Nature Communications108 citations Open access
Semantic Scholar
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights
S. Sujit, M. Aminu, Tatiana V. Karpinets, Pingjun Chen +33 more
2024Nature Communications106 citations Open access
Semantic Scholar
Poziotinib for EGFR exon 20 mutant NSCLC: clinical efficacy, resistance mechanisms and impact of insertion location on drug sensitivity
Y. Elamin, J. Robichaux, B. Carter, M. Altan +23 more
2022Cancer Cell96 citations Open access
Semantic Scholar
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Maliazurina B. Saad, L. Hong, M. Aminu, N. Vokes +45 more
2023The Lancet Digital Health95 citations Open access
Semantic Scholar
CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance
M. Nilsson, Yan Yang, S. Heeke, Sonia A Patel +23 more
2023Cancer Cell95 citations Open access
Semantic Scholar
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer
B. Sepesi, N. Zhou, W. William, Heather Y. Lin +19 more
2022Journal of Thoracic and Cardiovascular Surgery81 citations Open access
Semantic Scholar
Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and Metastasis
Mabel Perez-Oquendo, D. Gibbons
2022Cancers67 citations Open access
Semantic Scholar
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis
Rakhee Bajaj, Amanda N. Warner, Jared F Fradette, D. Gibbons
2022Cells59 citations Open access
Semantic Scholar
Archival single cell genomics reveals persistent subclones during DCIS progression
Kaile Wang, T. Kumar, Junke Wang, Darlan C. Minussi +28 more
2023Cell54 citations Open access
Semantic Scholar
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
M. Salehjahromi, Tatiana V. Karpinets, S. Sujit, Mohamed Qayati +33 more
2024Cell Reports Medicine47 citations Open access
Semantic Scholar
IL-6 mediates suppression of T and NK cells function in EMT-associated TKI-resistant EGFR mutant NSCLC
Sonia A Patel, M. Nilsson, Yan Yang, X. Le +13 more
2023Clinical Cancer Research45 citations Open access
Semantic Scholar
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
L. Hong, M. Aminu, Shen-Duo Li, Xuetao Lu +33 more
2023Nature Communications42 citations Open access
Semantic Scholar
Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer
E. Parra, Jie-Xin Zhang, Mei Jiang, A. Tamegnon +9 more
2023Nature Communications37 citations Open access
Semantic Scholar
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.
Yufei Liu, L. Yao, N. Kalhor, B. Carter +15 more
2022Lung Cancer32 citations
Semantic Scholar
EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer
G. Xiao, Xiao-Chao Tan, B. L. Rodriguez, D. Gibbons +14 more
2023Proceedings of the National Academy of Sciences of the United States of America31 citations Open access
Semantic Scholar
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes
P. Shah, M. Forget, M. Frank, Peixin Jiang +24 more
2022Journal for ImmunoTherapy of Cancer29 citations Open access
Semantic Scholar
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma
Pingjun Chen, Frank R. Rojas, Xin Hu, Alejandra G. Serrano +24 more
2023Modern Pathology28 citations Open access
Semantic Scholar
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti–PD-1 resistance in non–small cell lung cancer
J. Konen, B. L. Rodriguez, Hao-Yi Wu, Jared J. Fradette +7 more
2023Journal of Clinical Investigation28 citations Open access
Semantic Scholar
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
R. Thummalapalli, B. Ricciuti, C. Bandlamudi, Daniel M Muldoon +24 more
2023Clinical Cancer Research28 citations Open access
Semantic Scholar
ATM mutations associate with distinct co-mutational patterns and therapeutic vulnerabilities in NSCLC
N. Vokes, A. Cobo, Margarita Fernandez-Chas, D. Molkentine +20 more
2023Clinical Cancer Research28 citations Open access
Semantic Scholar
697 A phase 1 study of AMG 119, a DLL3-targeting, chimeric antigen receptor (CAR) T cell therapy, in relapsed/refractory small cell lung cancer (SCLC)
L. Byers, J. Heymach, D. Gibbons, Jian-Jun Zhang +5 more
2022Regular and Young Investigator Award Abstracts28 citations Open access
Semantic Scholar
EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer
Jihoon Kang, Jaemoo Chun, J. S. Hwang, Chao-Yun Pan +11 more
2022Cell Reports28 citations Open access
Semantic Scholar
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience
M. Altan, F. Soto, Linda L Zhong, F. Akhmedzhanov +24 more
2023The Oncologist27 citations Open access
Semantic Scholar
The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response
S. Kundu, B. L. Rodriguez, Laura Gibson, Amanda N Warner +14 more
2022Genes & Development26 citations Open access
Semantic Scholar
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages
Chia-Nung Hung, Meizhen Chen, D. DeArmond, Cheryl H.-L. Chiu +20 more
2023Cell Reports25 citations Open access
Semantic Scholar
Case report: rapid intracranial response with tarlatamab in patients with untreated brain metastases from small cell lung cancer-- a real-world case series
Bingnan Zhang, Komal Shah, Mitchell Parma, Kai-Wen Wang +24 more
2025Journal of Thoracic Oncology24 citations Open access
Semantic Scholar
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
Yufei Liu, Zhe Zhang, W. Rinsurongkawong, C. Gay +14 more
2022JAMA Network Open22 citations Open access
Semantic Scholar
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance
B. L. Rodriguez, Limo Chen, Yanli Li, S. Miao +13 more
2023Frontiers in Immunology17 citations Open access
Semantic Scholar
Adapting Nanopore Sequencing Basecalling Models for Modification Detection via Incremental Learning and Anomaly Detection
C. Stewart, L. Diao, Y. Xi, Runsheng Wang +25 more
2023bioRxiv17 citations Open access
Semantic Scholar
Distinct immune gene programs associated with host tumor immunity, neoadjuvant chemotherapy and chemoimmunotherapy in resectable NSCLC
P. Rocha, Jie-Xin Zhang, R. Laza-Briviesca, A. Cruz-Bermúdez +20 more
2022Clinical Cancer Research16 citations Open access
Semantic Scholar
Abstract 3317: KRASmulti inhibitor BI 3706674 shows efficacy in KRAS-driven preclinical models of cancer that supports clinical testing in patients with tumors harbouring KRASG12V mutations and KRAS wild-type amplifications
Antonio Tedeschi, David H. Peng, Fiorella Schischlik, Lorenz Herdeis +35 more
2024Cancer Research13 citations
Semantic Scholar
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
L. Hong, W. Lewis, M. Nilsson, Sonia A Patel +18 more
2022Cancers13 citations Open access
Semantic Scholar
ZEB1 is regulated by K811 acetylation to promote stability, NuRD complex interactions, EMT, and NSCLC metastasis
Mabel Perez-Oquendo, Roxsan Manshouri, Yan-Hua Tian, Jared J. Fradette +3 more
2023Molecular Cancer Research12 citations Open access
Semantic Scholar
Anti-tumor activity of a novel LAIR1 antagonist in combination with anti-PD-1 to treat collagen-rich solid tumors
B. L. Rodriguez, Jia-Wei Huang, Laura Gibson, Jared J. Fradette +17 more
2024Molecular Cancer Therapeutics11 citations
Semantic Scholar
Surgical Approach Does Not Influence Changes in Circulating Immune Cell Populations Following Lung Cancer Resection
Nathaniel Deboever, D. McGrail, Younghee Lee, H. Tran +18 more
2022Lung Cancer9 citations Open access
Semantic Scholar
Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung adenocarcinomas
Raisa A. Reyes-Castro, Shin-Yu Chen, Jacob Seemann, S. Kundu +2 more
2023Science Advances8 citations Open access
Semantic Scholar
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer.
M. Altan, E. Singhi, M. Worst, B. Carter +11 more
2022Clinical Lung Cancer8 citations
Semantic Scholar
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes
S. Seth, Run-Zhe Chen, Yang Liu, J. Fujimoto +21 more
2024Cancer Innovation7 citations Open access
Semantic Scholar
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC
Kai-Wen Wang, Robyn Du, S. Roy-Chowdhuri, Zi-Ping Li +21 more
2023JTO Clinical and Research Reports7 citations Open access
Semantic Scholar
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set.
S. Schmidt, N. Akhave, R. Knightly, A. Reuben +30 more
2022JCO Clinical Cancer Informatics7 citations Open access
Semantic Scholar
Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
Sehrish Qureshi, Naszrin Arani, Vishnupriyadevi Parvathareddy, A. Tchakarov +7 more
2023Frontiers in Nephrology4 citations Open access
Semantic Scholar
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy
Kang Qin, Kai-Wen Wang, Shen-Duo Li, L. Hong +16 more
2024Cancers3 citations Open access
Semantic Scholar
Clinical outcome and potential benefits of post-progression immunotherapy for patients with metastatic NSCLC with primary resistance to ipilumumab and nivolumab in the LONESTAR phase III study.
M. Altan, Da-Wen Sui, S. Gandhi, S. Swisher +16 more
2022Journal of Clinical Oncology3 citations
Semantic Scholar
Abstract 1212: Impact of KEAP1/STK11 co-mutations and NRF2 signaling on resistance to adagrasib in advanced NSCLC
M. Negrao, D. Molkentine, A. G. Paula, Laura D Hover +15 more
2024Cancer Research2 citations
Semantic Scholar
Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features
Hui Li, Xin Hu, Matthew S. Ning, G. Fuller +10 more
2024Frontiers in Oncology2 citations Open access
Semantic Scholar
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.
S. Heeke, S. Gandhi, H. Tran, V. Lam +16 more
2023Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract 4264: The genomic landscape of RET fusions in non-small cell lung cancer and the impact of co-occurring genomic alterations on the efficacy of selective RET inhibitors
Tuqa Al Khalaf, S. Heeke, Lei Feng, L. Drusbosky +11 more
2023Cancer Research2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Heymach×35
Invite
J. Heymach — researcher profile on SciRah
Jian-Jun Zhang×22
Invite
Jian-Jun Zhang — researcher profile on SciRah
A. Vaporciyan×18
Invite
A. Vaporciyan — researcher profile on SciRah
N. Vokes×16
Invite
N. Vokes — researcher profile on SciRah

×15

Invite

T. Cascone — researcher profile on SciRah

Invite

M. Negrao — researcher profile on SciRah

Invite

X. Le — researcher profile on SciRah

Invite

Y. Elamin — researcher profile on SciRah

Invite

M. Altan — researcher profile on SciRah

Invite

I. Wistuba — researcher profile on SciRah

Invite

L. Hong — researcher profile on SciRah

Invite

B. Sepesi — researcher profile on SciRah